• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Development of three human small cell lung cancer models in nude mice.

作者信息

Fiebig H H, Neumann H A, Henss H, Koch H, Kaiser D, Arnold H

出版信息

Recent Results Cancer Res. 1985;97:77-86. doi: 10.1007/978-3-642-82372-5_8.

DOI:10.1007/978-3-642-82372-5_8
PMID:2986247
Abstract

The transplantation of seven human small cell lung cancers (SCLC) into athymic nude mice resulted in the development of three tumor lines that are suitable for study of biology and for tests of new drugs and combinations. They were characterized and the response to known drugs was determined. An identical tumor response was observed in the nude mouse system and in the patient in all four comparisons available.

摘要

相似文献

1
Development of three human small cell lung cancer models in nude mice.
Recent Results Cancer Res. 1985;97:77-86. doi: 10.1007/978-3-642-82372-5_8.
2
Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.生长抑素类似物RC - 160及蛙皮素/胃泌素释放肽拮抗剂对裸鼠人小细胞和非小细胞肺癌生长的影响
Br J Cancer. 1994 Nov;70(5):886-92. doi: 10.1038/bjc.1994.415.
3
Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.顺铂和/或异环磷酰胺联合依托泊苷对人小细胞肺癌异种移植物的独特增效作用。
Clin Cancer Res. 2000 May;6(5):2075-86.
4
Adding a reverser (verapamil) to combined chemotherapy overrides resistance in small cell lung cancer xenografts.在联合化疗中加入逆转剂（维拉帕米）可克服小细胞肺癌异种移植瘤的耐药性。
Eur J Cancer. 1995 Oct;31A(11):1862-8. doi: 10.1016/0959-8049(95)00386-w.
5
Characterization of somatostatin receptors and growth inhibition by the somatostatin analogue BIM23014 in small cell lung carcinoma xenograft: SCLC-6.生长抑素受体的特性及生长抑素类似物BIM23014对小细胞肺癌异种移植瘤SCLC-6的生长抑制作用
Life Sci. 1994;55(2):155-62. doi: 10.1016/0024-3205(94)90107-4.
6
BW 1023U90: a new GRP receptor antagonist for small-cell lung cancer cells.
Peptides. 1996;17(8):1337-43. doi: 10.1016/s0196-9781(96)00195-7.
7
Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.缓激肽拮抗剂二聚体CU201在体外和体内均能抑制人肺癌细胞系的生长，并与其他抗肿瘤药物联合使用时产生协同生长抑制作用。
Clin Cancer Res. 2002 May;8(5):1280-7.
8
Orthotopic reconstitution of human small-cell lung carcinoma after intravenous transplantation in SCID mice.人小细胞肺癌在SCID小鼠静脉移植后的原位重建
Anticancer Res. 1992 Sep-Oct;12(5):1407-10.
9
Establishment and characterization of five human small cell lung cancer cell lines from early tumor xenografts.从早期肿瘤异种移植中建立并鉴定五个人类小细胞肺癌细胞系。
Anticancer Res. 1994 Sep-Oct;14(5A):1893-901.
10
Long-term maintenance therapy of established human small cell variant lung carcinoma implants in athymic mice with a cyclic regimen of difluoromethylornithine.用二氟甲基鸟氨酸的循环方案对无胸腺小鼠体内已建立的人小细胞变异型肺癌植入物进行长期维持治疗。
Cancer Res. 1986 Apr;46(4 Pt 1):1849-53.

引用本文的文献

1
Human lncRNAs NEAT1 and MALAT1 regulate the tumor microenvironment in lung cancer PDX models in athymic nude mice.人类长链非编码RNA NEAT1和MALAT1在无胸腺裸鼠的肺癌人源肿瘤异种移植（PDX）模型中调节肿瘤微环境。
Sci Rep. 2025 Jul 2;15(1):23472. doi: 10.1038/s41598-025-05157-z.
2
PDX models for functional precision oncology and discovery science.用于功能精准肿瘤学和发现科学的人源肿瘤异种移植模型
Nat Rev Cancer. 2025 Mar;25(3):153-166. doi: 10.1038/s41568-024-00779-3. Epub 2024 Dec 16.
3
Lessons learned from 20 years of preclinical testing in pediatric cancers.
从20年儿科癌症临床前测试中吸取的经验教训。
Pharmacol Ther. 2024 Dec;264:108742. doi: 10.1016/j.pharmthera.2024.108742. Epub 2024 Nov 5.
4
Patient-derived organoids (PDOs) and PDO-derived xenografts (PDOXs): New opportunities in establishing faithful pre-clinical cancer models.患者来源的类器官（PDO）和PDO衍生的异种移植物（PDOX）：建立可靠的临床前癌症模型的新机遇。
J Natl Cancer Cent. 2022 Oct 22;2(4):263-276. doi: 10.1016/j.jncc.2022.10.001. eCollection 2022 Dec.
5
Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.用于前列腺癌转化研究和药物开发的患者来源异种移植模型。
Methods Mol Biol. 2024;2806:153-185. doi: 10.1007/978-1-0716-3858-3_12.
6
Addressing a Pre-Clinical Pipeline Gap: Development of the Pediatric Acute Myeloid Leukemia Patient-Derived Xenograft Program at Texas Children's Hospital at Baylor College of Medicine.填补临床前研发空白：贝勒医学院德克萨斯儿童医院小儿急性髓系白血病患者来源异种移植项目的开展
Biomedicines. 2024 Feb 8;12(2):394. doi: 10.3390/biomedicines12020394.
7
Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts).与患者来源的肿瘤植入物（患者来源的异种移植）在小鼠体内生长相关的患者特征
Cancers (Basel). 2023 Nov 14;15(22):5402. doi: 10.3390/cancers15225402.
8
Exploitation of Sulfated Glycosaminoglycan Status for Precision Medicine of Triplatin in Triple-Negative Breast Cancer.三阴性乳腺癌中三铂类药物精准医学用硫酸化糖胺聚糖状态的开发。
Mol Cancer Ther. 2022 Feb;21(2):271-281. doi: 10.1158/1535-7163.MCT-20-0969. Epub 2021 Nov 23.
9
Current Status and Perspectives of Patient-Derived Models for Ewing's Sarcoma.尤因肉瘤患者来源模型的现状与展望
Cancers (Basel). 2020 Sep 4;12(9):2520. doi: 10.3390/cancers12092520.
10
Current status and perspectives of patient-derived rare cancer models.患者来源的罕见癌症模型的现状与展望。
Hum Cell. 2020 Oct;33(4):919-929. doi: 10.1007/s13577-020-00391-1. Epub 2020 Jun 14.